Curcumin: A Challenge in Cancer Treatment
نویسندگان
چکیده
منابع مشابه
Curcumin Nanoformulation for Cervical Cancer Treatment
Cervical cancer is one of the most common cancers among women worldwide. Current standards of care for cervical cancer includes surgery, radiation, and chemotherapy. Conventional chemotherapy fails to elicit therapeutic responses and causes severe systemic toxicity. Thus, developing a natural product based, safe treatment modality would be a highly viable option. Curcumin (CUR) is a well-known ...
متن کاملHybrid curcumin compounds: a new strategy for cancer treatment.
Cancer is a multifactorial disease that requires treatments able to target multiple intracellular components and signaling pathways. The natural compound, curcumin, was already described as a promising anticancer agent due to its multipotent properties and huge amount of molecular targets in vitro. Its translation to the clinic is, however, limited by its reduced solubility and bioavailability ...
متن کاملRole of nano-curcumin: A treatment for cancer
Conventional therapies of cancer cause serious side effects, systemic toxicity, poor quality of life of patients, accompanied with tumor resistance and recurrence which discourage their long term use. Therefore, highly precise anticancer therapies with minimal side effects are needed to be identified. Curcumin’s widespread availability, safety, low cost and anticancer activity justify its devel...
متن کاملPoly Drug Use - A Challenge for Drug Treatment
Poly-drug use refers to the use of two or more substances at the one time or repeatedly. It is common among both recreational and regular drug users across the world. Poly-drug use is a great contributor to the global number of deaths related to drug overdose. In this case, the likelihood of drug overdose and its pertaining complications in an individual is higher especially when benzodiazepine...
متن کاملThe multifaceted role of curcumin in cancer prevention and treatment.
Despite significant advances in treatment modalities over the last decade, neither the incidence of the disease nor the mortality due to cancer has altered in the last thirty years. Available anti-cancer drugs exhibit limited efficacy, associated with severe side effects, and are also expensive. Thus identification of pharmacological agents that do not have these disadvantages is required. Curc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Nepal Pharmaceutical Association
سال: 2012
ISSN: 0253-8261
DOI: 10.3126/jnpa.v26i1.6631